Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ULTRAVIOLET FIM_A First-In-Man Single Arm Prospective Single Center Study to Assess Safety and Efficacy of Ultra High Pressure PTA Balloon ULTRAVIOLET in Treating A-V Fistula Stenosis

NCT07330817 is registered in ClinicalTrials.gov with Cardionovum GmbH as lead sponsor.

NCT NCT07330817
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07330817 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ULTRAVIOLET FIM_A First-In-Man Single Arm Prospective Single Center Study to Assess Safety and Efficacy of Ultra High Pressure PTA Balloon ULTRAVIOLET in Treating A-V Fistula Stenosis
Lead sponsor
Cardionovum GmbH
Phase
Not applicable
Overall status
Not yet recruiting
Start date
February 28, 2026
Completion date
February 28, 2027
Enrollment
35 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arterio-venous fistula, stenosis of arteriovenous dialysis fistula